Ming-Sound Tsao - Publications

Medical Biophysics University of Toronto, Toronto, ON, Canada 
Oncology, Molecular Biology, Cell Biology, General Biophysics

207 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Pham NA, Radulovich N, Ibrahimov E, Martins-Filho SN, Li Q, Pintilie M, Weiss J, Raghavan V, Cabanero M, Denroche RE, Wilson JM, Metran-Nascente C, Borgida A, Hutchinson S, Dodd A, ... ... Tsao MS, et al. Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers. Scientific Reports. 11: 10619. PMID 34011980 DOI: 10.1038/s41598-021-90049-1  0.76
2020 Derouet MF, Allen J, Wilson GW, Ng C, Radulovich N, Kalimuthu S, Tsao MS, Darling GE, Yeung JC. Towards personalized induction therapy for esophageal adenocarcinoma: organoids derived from endoscopic biopsy recapitulate the pre-treatment tumor. Scientific Reports. 10: 14514. PMID 32884042 DOI: 10.1093/Dote/Doaa087.86  0.76
2020 Saraon P, Snider J, Kalaidzidis Y, Wybenga-Groot LE, Weiss K, Rai A, Radulovich N, Drecun L, Vučković N, Vučetić A, Wong V, Thériault B, Pham NA, Park JH, Datti A, ... ... Tsao MS, et al. A drug discovery platform to identify compounds that inhibit EGFR triple mutants. Nature Chemical Biology. PMID 32094923 DOI: 10.1038/S41589-020-0484-2  0.76
2019 Shi R, Radulovich N, Ng C, Liu N, Notsuda H, Cabanero M, N Martins-Filho S, Raghavan V, Li Q, Mer AS, Rosen JC, Li M, Wang YH, Tamblyn L, Pham NA, ... ... Tsao MS, et al. Organoid cultures as preclinical models of non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31694835 DOI: 10.1158/1078-0432.Ccr-19-1376  0.76
2019 Joseph J, Radulovich N, Wang T, Raghavan V, Zhu CQ, Tsao MS. Rho guanine nucleotide exchange factor ARHGEF10 is a putative tumor suppressor in pancreatic ductal adenocarcinoma. Oncogene. PMID 31477830 DOI: 10.1038/S41388-019-0985-1  0.76
2019 Kano Y, Gebregiworgis T, Marshall CB, Radulovich N, Poon BPK, St-Germain J, Cook JD, Valencia-Sama I, Grant BMM, Herrera SG, Miao J, Raught B, Irwin MS, Lee JE, Yeh JJ, ... ... Tsao MS, et al. Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation. Nature Communications. 10: 224. PMID 30644389 DOI: 10.1038/S41467-018-08115-8  0.76
2019 Gendoo DMA, Denroche RE, Zhang A, Radulovich N, Jang GH, Lemire M, Fischer S, Chadwick D, Lungu IM, Ibrahimov E, Cao PJ, Stein LD, Wilson JM, Bartlett JMS, Tsao MS, et al. Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer. Plos Computational Biology. 15: e1006596. PMID 30629588 DOI: 10.1371/Journal.Pcbi.1006596  0.76
2018 Gebregiworgis T, Marshall CB, Nishikawa T, Radulovich N, Sandi MJ, Fang Z, Rottapel R, Tsao MS, Ikura M. Multiplexed real-time NMR GTPase assay for simultaneous monitoring of multiple GEF activities from human cancer cells and organoids. Journal of the American Chemical Society. PMID 29543440 DOI: 10.1021/Jacs.7B13703  0.76
2018 Gebregiworgis T, Marshall CB, Kano Y, Radulovich N, Tsao M, Ohh M, Ikura M. Abstract 4360: Altering the regulation of KRAS GTPase cycle via Src and SHP2 creates a potential therapeutic vulnerability for pancreatic cancer Cancer Research. 78: 4360-4360. DOI: 10.1158/1538-7445.Am2018-4360  0.76
2016 Kim BR, Van de Laar E, Cabanero M, Tarumi S, Hasenoeder S, Wang D, Virtanen C, Suzuki T, Bandarchi B, Sakashita S, Pham NA, Lee S, Keshavjee S, Waddell TK, Tsao MS, et al. SOX2 and PI3K Cooperate to Induce and Stabilize a Squamous-Committed Stem Cell Injury State during Lung Squamous Cell Carcinoma Pathogenesis. Plos Biology. 14: e1002581. PMID 27880766 DOI: 10.1371/Journal.Pbio.1002581  0.32
2016 Notta F, Chan-Seng-Yue M, Lemire M, Li Y, Wilson GW, Connor AA, Denroche RE, Liang SB, Brown AM, Kim JC, Wang T, Simpson JT, Beck T, Borgida A, Buchner N, ... ... Tsao MS, et al. Erratum: A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns. Nature. PMID 27851734 DOI: 10.1038/nature20164  0.32
2016 Wang D, Pham NA, Tong J, Sakashita S, Allo G, Kim L, Yanagawa N, Raghavan V, Wei Y, To C, Trinh QM, Starmans MH, Chan-Seng-Yue MA, Chadwick D, Li L, ... ... Tsao MS, et al. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors. International Journal of Cancer. PMID 27750381 DOI: 10.1002/Ijc.30472  0.32
2016 Notta F, Chan-Seng-Yue M, Lemire M, Li Y, Wilson GW, Connor AA, Denroche RE, Liang SB, Brown AM, Kim JC, Wang T, Simpson JT, Beck T, Borgida A, Buchner N, ... ... Tsao MS, et al. A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns. Nature. PMID 27732578 DOI: 10.1038/Nature19823  0.32
2016 Wang T, Notta F, Navab R, Joseph J, Ibrahimov E, Xu J, Zhu CQ, Borgida A, Gallinger S, Tsao MS. Senescent Carcinoma-associated Fibroblasts Upregulate IL8 to Enhance Pro-metastatic Phenotypes. Molecular Cancer Research : McR. PMID 27678171 DOI: 10.1158/1541-7786.Mcr-16-0192  0.32
2016 Ritchie AJ, Sanghera C, Jacobs C, Zhang W, Mayo J, Schmidt H, Gingras M, Pasian S, Stewart L, Tsai S, Manos D, Seely JM, Burrowes P, Bhatia R, Atkar-Khattra S, ... ... Tsao MS, et al. Computer Vision Tool and Technician as First Reader of Lung Cancer Screening CT Scans. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 26994641 DOI: 10.1016/J.Jtho.2016.01.021  0.68
2015 Cannell IG, Merrick KA, Morandell S, Zhu CQ, Braun CJ, Grant RA, Cameron ER, Tsao MS, Hemann MT, Yaffe MB. A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy. Cancer Cell. PMID 26602816 DOI: 10.1016/j.ccell.2015.09.009  0.68
2015 Huang L, Holtzinger A, Jagan I, BeGora M, Lohse I, Ngai N, Nostro C, Wang R, Muthuswamy LB, Crawford HC, Arrowsmith C, Kalloger SE, Renouf DJ, Connor AA, Cleary S, ... ... Tsao MS, et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nature Medicine. PMID 26501191 DOI: 10.1038/Nm.3973  0.68
2015 Kerr KM, Tsao MS, Nicholson AG, Yatabe Y, Wistuba II, Hirsch FR. Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art? Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 985-9. PMID 26134220 DOI: 10.1097/JTO.0000000000000526  0.68
2015 Stewart EL, Mascaux C, Pham NA, Sakashita S, Sykes J, Kim L, Yanagawa N, Allo G, Ishizawa K, Wang D, Zhu CQ, Li M, Ng C, Liu N, Pintilie M, ... ... Tsao MS, et al. Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26124487 DOI: 10.1200/Jco.2014.60.1492  0.68
2015 Nakajima T, Geddie W, Anayama T, Ko HM, da Cunha Santos G, Boerner S, Wang T, Wang YH, Li M, Pham NA, Tsao MS, Yasufuku K. Patient-derived tumor xenograft models established from samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration. Lung Cancer (Amsterdam, Netherlands). 89: 110-4. PMID 26095073 DOI: 10.1016/j.lungcan.2015.05.018  0.68
2015 Huang S, Reitze NJ, Ewing AL, McCreary S, Uihlein AH, Brower SL, Wang D, Wang T, Gabrin MJ, Keating KE, Mulligan J, Wilson C, Davison T, McKenzie S, Tsao MS, et al. Analytical Performance of a 15-Gene Prognostic Assay for Early-Stage Non-Small-Cell Lung Carcinoma Using RNA-Stabilized Tissue. The Journal of Molecular Diagnostics : Jmd. 17: 438-45. PMID 25960256 DOI: 10.1016/J.Jmoldx.2015.03.005  0.68
2015 Dodbiba L, Teichman J, Fleet A, Thai H, Starmans MH, Navab R, Chen Z, Girgis H, Eng L, Espin-Garcia O, Shen X, Bandarchi B, Schwock J, Tsao MS, El-Zimaity H, et al. Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers. Plos One. 10: e0121872. PMID 25826681 DOI: 10.1371/Journal.Pone.0121872  0.68
2015 Stewart EL, Tan SZ, Liu G, Tsao MS. Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review. Translational Lung Cancer Research. 4: 67-81. PMID 25806347 DOI: 10.3978/J.Issn.2218-6751.2014.11.06  0.68
2015 Wei Y, Vellanki RN, Coyaud É, Ignatchenko V, Li L, Krieger JR, Taylor P, Tong J, Pham NA, Liu G, Raught B, Wouters BG, Kislinger T, Tsao MS, Moran MF. CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration. Molecular Cancer Research : McR. 13: 1119-29. PMID 25784717 DOI: 10.1158/1541-7786.Mcr-14-0165-T  0.68
2015 Leung JM, Mayo J, Tan W, Tammemagi CM, Liu G, Peacock S, Shepherd FA, Goffin J, Goss G, Nicholas G, Tremblay A, Johnston M, Martel S, Laberge F, Bhatia R, ... ... Tsao MS, et al. Plasma pro-surfactant protein B and lung function decline in smokers. The European Respiratory Journal. 45: 1037-45. PMID 25614175 DOI: 10.1183/09031936.00184214  0.68
2015 Starmans MH, Pintilie M, Chan-Seng-Yue M, Moon NC, Haider S, Nguyen F, Lau SK, Liu N, Kasprzyk A, Wouters BG, Der SD, Shepherd FA, Jurisica I, Penn LZ, Tsao MS, et al. Integrating RAS status into prognostic signatures for adenocarcinomas of the lung. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1477-86. PMID 25609067 DOI: 10.1158/1078-0432.Ccr-14-1749  0.68
2015 Pitz MW, Eisenhauer EA, MacNeil MV, Thiessen B, Easaw JC, Macdonald DR, Eisenstat DD, Kakumanu AS, Salim M, Chalchal H, Squire J, Tsao MS, Kamel-Reid S, Banerji S, Tu D, et al. Phase II study of PX-866 in recurrent glioblastoma. Neuro-Oncology. PMID 25605819 DOI: 10.1093/Neuonc/Nou365  0.68
2015 Lohse I, Cao P, Ibrahimov E, Tsao M, Hedley DW. Abstract A106: BRCA mutation sensitizes pancreatic tumors to treatment with cisplatin Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-A106  0.32
2015 Lohse I, Rasowski J, Cao P, Pintilie M, Do T, Ibrahimov E, Tsao M, Hill RP, Hedley DW. Abstract A102: Combination treatment with hypoxia-activated prodrug TH-302 and radiation reduce pancreatic tumor initiating cells and tumor growth in patient-derived xenografts Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-A102  0.32
2014 Zhu CQ, Tsao MS. Prognostic markers in lung cancer: is it ready for prime time? Translational Lung Cancer Research. 3: 149-58. PMID 25806294 DOI: 10.3978/J.Issn.2218-6751.2014.06.09  0.68
2014 Thu KL, Becker-Santos DD, Radulovich N, Pikor LA, Lam WL, Tsao MS. SOX15 and other SOX family members are important mediators of tumorigenesis in multiple cancer types. Oncoscience. 1: 326-35. PMID 25594027  0.76
2014 Ellis PM, Shepherd FA, Millward M, Perrone F, Seymour L, Liu G, Sun S, Cho BC, Morabito A, Leighl NB, Stockler MR, Lee CW, Wierzbicki R, Cohen V, Blais N, ... ... Tsao MS, et al. Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial. The Lancet. Oncology. 15: 1379-88. PMID 25439692 DOI: 10.1016/S1470-2045(14)70472-3  0.68
2014 Li L, Wei Y, To C, Zhu CQ, Tong J, Pham NA, Taylor P, Ignatchenko V, Ignatchenko A, Zhang W, Wang D, Yanagawa N, Li M, Pintilie M, Liu G, ... ... Tsao MS, et al. Integrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact. Nature Communications. 5: 5469. PMID 25429762 DOI: 10.1038/Ncomms6469  0.32
2014 Tsao MS, Travis WD, Brambilla E, Nicholson AG, Noguchi M, Hirsch FR. Forty years of the international association for study of lung cancer pathology committee. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 1740-9. PMID 25393791 DOI: 10.1097/Jto.0000000000000356  0.68
2014 Radulovich N, Leung L, Ibrahimov E, Navab R, Sakashita S, Zhu CQ, Kaufman E, Lockwood WW, Thu KL, Fedyshyn Y, Moffat J, Lam WL, Tsao MS. Coiled-coil domain containing 68 (CCDC68) demonstrates a tumor-suppressive role in pancreatic ductal adenocarcinoma. Oncogene. PMID 25381825 DOI: 10.1038/Onc.2014.357  0.68
2014 Golaraei A, Cisek R, Krouglov S, Navab R, Niu C, Sakashita S, Yasufuku K, Tsao MS, Wilson BC, Barzda V. Characterization of collagen in non-small cell lung carcinoma with second harmonic polarization microscopy. Biomedical Optics Express. 5: 3562-7. PMID 25360372 DOI: 10.1364/Boe.5.003562  0.68
2014 Tsoref D, Welch S, Lau S, Biagi J, Tonkin K, Martin LA, Ellard S, Ghatage P, Elit L, Mackay HJ, Allo G, Tsao MS, Kamel-Reid S, Eisenhauer EA, Oza AM. Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer. Gynecologic Oncology. 135: 184-9. PMID 25173583 DOI: 10.1016/J.Ygyno.2014.06.033  0.68
2014 Thunnissen E, Noguchi M, Aisner S, Beasley MB, Brambilla E, Chirieac LR, Chung JH, Dacic S, Geisinger KR, Hirsch FR, Ishikawa Y, Kerr KM, Lantejoul S, Matsuno Y, Minami Y, ... ... Tsao MS, et al. Reproducibility of histopathological diagnosis in poorly differentiated NSCLC: an international multiobserver study. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 1354-62. PMID 25122431 DOI: 10.1097/JTO.0000000000000264  0.68
2014 Cutz JC, Craddock KJ, Torlakovic E, Brandao G, Carter RF, Bigras G, Deschenes J, Izevbaye I, Xu Z, Greer W, Yatabe Y, Ionescu D, Karsan A, Jung S, Fraser RS, ... ... Tsao MS, et al. Canadian anaplastic lymphoma kinase study: a model for multicenter standardization and optimization of ALK testing in lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 1255-63. PMID 25122422 DOI: 10.1097/Jto.0000000000000239  0.68
2014 Cressman S, Lam S, Tammemagi MC, Evans WK, Leighl NB, Regier DA, Bolbocean C, Shepherd FA, Tsao MS, Manos D, Liu G, Atkar-Khattra S, Cromwell I, Johnston MR, Mayo JR, et al. Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 1449-58. PMID 25105438 DOI: 10.1097/Jto.0000000000000283  0.68
2014 Kim L, Tsao MS. Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing? The European Respiratory Journal. 44: 1011-22. PMID 25102961 DOI: 10.1183/09031936.00197013  0.68
2014 Shiau CJ, Babwah JP, da Cunha Santos G, Sykes JR, Boerner SL, Geddie WR, Leighl NB, Wei C, Kamel-Reid S, Hwang DM, Tsao MS. Sample features associated with success rates in population-based EGFR mutation testing. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 947-56. PMID 24922009 DOI: 10.1097/Jto.0000000000000196  0.68
2014 Azad AK, Qiu X, Boyd K, Kuang Q, Emami M, Perera N, Palepu P, Patel D, Chen Z, Cheng D, Feld R, Leighl NB, Shepherd FA, Tsao MS, Xu W, et al. A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC). Lung Cancer (Amsterdam, Netherlands). 84: 289-94. PMID 24679952 DOI: 10.1016/J.Lungcan.2014.03.008  0.68
2014 Cooper W, Fox S, O'Toole S, Morey A, Frances G, Pavlakis N, O'Byrne K, Dettrick A, Leong T, Rathi V, Spagnolo D, Hemmings C, Singh M, Moffat D, Tsao MS, et al. National Working Group Meeting on ALK diagnostics in lung cancer. Asia-Pacific Journal of Clinical Oncology. 10: 11-7. PMID 24673736 DOI: 10.1111/Ajco.12190  0.68
2014 Petschnigg J, Groisman B, Kotlyar M, Taipale M, Zheng Y, Kurat CF, Sayad A, Sierra JR, Mattiazzi Usaj M, Snider J, Nachman A, Krykbaeva I, Tsao MS, Moffat J, Pawson T, et al. The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells. Nature Methods. 11: 585-92. PMID 24658140 DOI: 10.1038/Nmeth.2895  0.68
2014 Lohse I, Lourenco C, Ibrahimov E, Pintilie M, Tsao MS, Hedley DW. Assessment of hypoxia in the stroma of patient-derived pancreatic tumor xenografts. Cancers. 6: 459-71. PMID 24577243 DOI: 10.3390/cancers6010459  0.32
2014 Djalalov S, Beca J, Hoch JS, Krahn M, Tsao MS, Cutz JC, Leighl NB. Cost effectiveness of EML4-ALK fusion testing and first-line crizotinib treatment for patients with advanced ALK-positive non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 1012-9. PMID 24567430 DOI: 10.1200/JCO.2013.53.1186  0.68
2014 Cullis J, Meiri D, Sandi MJ, Radulovich N, Kent OA, Medrano M, Mokady D, Normand J, Larose J, Marcotte R, Marshall CB, Ikura M, Ketela T, Moffat J, Neel BG, ... ... Tsao MS, et al. The RhoGEF GEF-H1 is required for oncogenic RAS signaling via KSR-1. Cancer Cell. 25: 181-95. PMID 24525234 DOI: 10.1016/J.Ccr.2014.01.025  0.68
2014 Ragin C, Obikoya-Malomo M, Kim S, Chen Z, Flores-Obando R, Gibbs D, Koriyama C, Aguayo F, Koshiol J, Caporaso NE, Carpagnano GE, Ciotti M, Dosaka-Akita H, Fukayama M, Goto A, ... ... Tsao MS, et al. HPV-associated lung cancers: an international pooled analysis. Carcinogenesis. 35: 1267-75. PMID 24523449 DOI: 10.1093/Carcin/Bgu038  0.68
2014 Organ SL, Hai J, Radulovich N, Marshall CB, Leung L, Sasazuki T, Shirasawa S, Zhu CQ, Navab R, Ikura M, Tsao MS. p120RasGAP is a mediator of rho pathway activation and tumorigenicity in the DLD1 colorectal cancer cell line. Plos One. 9: e86103. PMID 24465899 DOI: 10.1371/Journal.Pone.0086103  0.68
2014 Tam S, de Borja R, Tsao MS, McPherson JD. Robust global microRNA expression profiling using next-generation sequencing technologies. Laboratory Investigation; a Journal of Technical Methods and Pathology. 94: 350-8. PMID 24445778 DOI: 10.1038/labinvest.2013.157  0.68
2014 Field JK, Aberle DR, Altorki N, Baldwin DR, Dresler C, Duffy SW, Goldstraw P, Hirsch FR, Pedersen JH, de Koning HJ, Mulshine JL, Sullivan DC, Tsao MS, Travis WD. The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) response to the USPSTF recommendations. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 141-3. PMID 24419409 DOI: 10.1097/Jto.0000000000000060  0.68
2014 Der SD, Sykes J, Pintilie M, Zhu CQ, Strumpf D, Liu N, Jurisica I, Shepherd FA, Tsao MS. Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 59-64. PMID 24305008 DOI: 10.1097/Jto.0000000000000042  0.68
2014 Wilson IM, Vucic EA, Enfield KS, Thu KL, Zhang YA, Chari R, Lockwood WW, Radulovich N, Starczynowski DT, Banáth JP, Zhang M, Pusic A, Fuller M, Lonergan KM, Rowbotham D, ... ... Tsao MS, et al. EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk. Oncogene. 33: 4464-73. PMID 24096489 DOI: 10.1038/Onc.2013.396  0.68
2014 Thu KL, Becker-Santos DD, Radulovich N, Pikor LA, Lam WL, Tsao MS. SOX15 and other SOX family members are important mediators of tumorigenesis in multiple cancer types Oncoscience. 1: 326-335. DOI: 10.18632/oncoscience.46  0.68
2014 Joseph J, Radulovich N, Tsao M. Abstract 1553: Rho guanine nucleotide exchange factor (ARHGEF) 10 is a putative tumor suppressor in pancreatic ductal adenocarcinoma Cancer Research. 74: 1553-1553. DOI: 10.1158/1538-7445.Am2014-1553  0.76
2014 Craddock KJ, Tam S, Zhu CQ, Tsao MS. Genomic pathology of lung cancer Cancer Genomics: Molecular Classification, Prognosis and Response Prediction. 1-46. DOI: 10.1007/978-94-007-5842-1_1  0.68
2014 Kim L, Liu G, Tsao MS. Predictive Tumor Biomarkers for EGFR Inhibitors Lung Cancer: Fourth Edition. 435-453. DOI: 10.1002/9781118468791.ch28  0.68
2013 Leung L, Radulovich N, Zhu CQ, Wang D, To C, Ibrahimov E, Tsao MS. Loss of canonical Smad4 signaling promotes KRAS driven malignant transformation of human pancreatic duct epithelial cells and metastasis. Plos One. 8: e84366. PMID 24386371 DOI: 10.1371/Journal.Pone.0084366  0.76
2013 Thunnissen E, Beliën JA, Kerr KM, Chung JH, Flieder DB, Noguchi M, Yatabe Y, Hwang DM, Lely RJ, Hartemink KJ, Meijer-Jorna LB, Tsao MS. In compressed lung tissue microscopic sections of adenocarcinoma in situ may mimic papillary adenocarcinoma. Archives of Pathology & Laboratory Medicine. 137: 1792-7. PMID 24283861 DOI: 10.5858/Arpa.2012-0613-Sa  0.68
2013 Craddock KJ, Ludkovski O, Sykes J, Shepherd FA, Tsao MS. Prognostic value of fibroblast growth factor receptor 1 gene locus amplification in resected lung squamous cell carcinoma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 1371-7. PMID 24077455 DOI: 10.1097/Jto.0B013E3182A46Fe9  0.68
2013 McWilliams A, Tammemagi MC, Mayo JR, Roberts H, Liu G, Soghrati K, Yasufuku K, Martel S, Laberge F, Gingras M, Atkar-Khattra S, Berg CD, Evans K, Finley R, Yee J, ... ... Tsao MS, et al. Probability of cancer in pulmonary nodules detected on first screening CT. The New England Journal of Medicine. 369: 910-9. PMID 24004118 DOI: 10.1056/Nejmoa1214726  0.68
2013 Goss GD, O'Callaghan C, Lorimer I, Tsao MS, Masters GA, Jett J, Edelman MJ, Lilenbaum R, Choy H, Khuri F, Pisters K, Gandara D, Kernstine K, Butts C, Noble J, et al. Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 3320-6. PMID 23980091 DOI: 10.1200/Jco.2013.51.1816  0.68
2013 Coe BP, Thu KL, Aviel-Ronen S, Vucic EA, Gazdar AF, Lam S, Tsao MS, Lam WL. Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer. Plos One. 8: e71670. PMID 23967231 DOI: 10.1371/journal.pone.0071670  0.68
2013 John T, Starmans MH, Chen YT, Russell PA, Barnett SA, White SC, Mitchell PL, Walkiewicz M, Azad A, Lambin P, Tsao MS, Deb S, Altorki N, Wright G, Knight S, et al. The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer. Plos One. 8: e67876. PMID 23935846 DOI: 10.1371/Journal.Pone.0067876  0.68
2013 Tsao MS, Jablons DM. Molecular prognostication of non-small cell lung cancer. Seminars in Thoracic and Cardiovascular Surgery. 25: 4-7. PMID 23800523 DOI: 10.1053/J.Semtcvs.2013.01.007  0.68
2013 Shepherd FA, Domerg C, Hainaut P, Jänne PA, Pignon JP, Graziano S, Douillard JY, Brambilla E, Le Chevalier T, Seymour L, Bourredjem A, Le Teuff G, Pirker R, Filipits M, Rosell R, ... ... Tsao MS, et al. Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2173-81. PMID 23630215 DOI: 10.1200/JCO.2012.48.1390  0.32
2013 Friboulet L, Olaussen KA, Pignon JP, Shepherd FA, Tsao MS, Graziano S, Kratzke R, Douillard JY, Seymour L, Pirker R, Filipits M, André F, Solary E, Ponsonnailles F, Robin A, et al. ERCC1 isoform expression and DNA repair in non-small-cell lung cancer. The New England Journal of Medicine. 368: 1101-10. PMID 23514287 DOI: 10.1056/NEJMoa1214271  0.68
2013 Dua P, Kang HS, Hong SM, Tsao MS, Kim S, Lee DK. Alkaline phosphatase ALPPL-2 is a novel pancreatic carcinoma-associated protein. Cancer Research. 73: 1934-45. PMID 23467613 DOI: 10.1158/0008-5472.Can-12-3682  0.68
2013 Craddock KJ, Lam WL, Tsao MS. Applications of array-CGH for lung cancer. Methods in Molecular Biology (Clifton, N.J.). 973: 297-324. PMID 23412798 DOI: 10.1007/978-1-62703-281-0_19  0.68
2013 Dodbiba L, Teichman J, Fleet A, Thai H, Sun B, Panchal D, Patel D, Tse A, Chen Z, Faluyi OO, Renouf DJ, Girgis H, Bandarchi B, Schwock J, Xu W, ... ... Tsao MS, et al. Primary esophageal and gastro-esophageal junction cancer xenograft models: clinicopathological features and engraftment. Laboratory Investigation; a Journal of Technical Methods and Pathology. 93: 397-407. PMID 23399854 DOI: 10.1038/Labinvest.2013.8  0.68
2013 Yanagawa N, Wang A, Kohler D, Santos Gda C, Sykes J, Xu J, Pintilie M, Tsao MS. Human papilloma virus genome is rare in North American non-small cell lung carcinoma patients. Lung Cancer (Amsterdam, Netherlands). 79: 215-20. PMID 23254264 DOI: 10.1016/J.Lungcan.2012.11.018  0.68
2013 Xu J, Knox JJ, Ibrahimov E, Chen E, Serra S, Tsao M, Cao P, Vines D, Green DE, Metran-Nascente C, McNamara MG, Hedley DW. Sequence dependence of MEK inhibitor AZD6244 combined with gemcitabine for the treatment of biliary cancer Clinical Cancer Research. 19: 118-127. PMID 23091117 DOI: 10.1158/1078-0432.Ccr-12-2557  0.68
2013 Du J, Nelson ES, Simons AL, Olney KE, Moser JC, Schrock HE, Wagner BA, Buettner GR, Smith BJ, Teoh ML, Tsao MS, Cullen JJ. Regulation of pancreatic cancer growth by superoxide. Molecular Carcinogenesis. 52: 555-67. PMID 22392697 DOI: 10.1002/Mc.21891  0.68
2013 Lohse I, Cao P, Do T, Ibrahimov E, Tsao M, Hedley DW. Abstract B282: The PLK-4 inhibitor CFI-400945 reduces tumor growth in patient-derived pancreatic xenografts. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-B282  0.32
2012 Di Maio M, Leighl NB, Gallo C, Feld R, Ciardiello F, Butts C, Maione P, Gebbia V, Morgillo F, Wierzbicki R, Favaretto A, Alam Y, Cinieri S, Siena S, Bianco R, ... ... Tsao MS, et al. Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 1830-44. PMID 23154555 DOI: 10.1097/JTO.0b013e318275b327  0.68
2012 Starmans MH, Pintilie M, John T, Der SD, Shepherd FA, Jurisica I, Lambin P, Tsao MS, Boutros PC. Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies. Genome Medicine. 4: 84. PMID 23146350 DOI: 10.1186/Gm385  0.68
2012 Leung L, Radulovich N, Zhu CQ, Organ S, Bandarchi B, Pintilie M, To C, Panchal D, Tsao MS. Lipocalin2 promotes invasion, tumorigenicity and gemcitabine resistance in pancreatic ductal adenocarcinoma. Plos One. 7: e46677. PMID 23056397 DOI: 10.1371/Journal.Pone.0046677  0.76
2012 Yanagawa N, Leduc C, Kohler D, Saieg MA, John T, Sykes J, Yoshimoto M, Pintilie M, Squire J, Shepherd FA, Tsao MS. Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 1513-21. PMID 22982652 DOI: 10.1097/Jto.0B013E3182641D4F  0.68
2012 Gridelli C, Ciardiello F, Gallo C, Feld R, Butts C, Gebbia V, Maione P, Morgillo F, Genestreti G, Favaretto A, Leighl N, Wierzbicki R, Cinieri S, Alam Y, Siena S, ... ... Tsao MS, et al. First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 3002-11. PMID 22778317 DOI: 10.1200/JCO.2011.41.2056  0.68
2012 Lockwood WW, Wilson IM, Coe BP, Chari R, Pikor LA, Thu KL, Solis LM, Nunez MI, Behrens C, Yee J, English J, Murray N, Tsao MS, Minna JD, Gazdar AF, et al. Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development. Plos One. 7: e37775. PMID 22629454 DOI: 10.1016/J.Cancergen.2011.08.014  0.68
2012 John T, Yanagawa N, Kohler D, Craddock KJ, Bandarchi-Chamkhaleh B, Pintilie M, Sykes J, To C, Li M, Panchal D, Chen W, Shepherd FA, Tsao MS. Characterization of lymphomas developing in immunodeficient mice implanted with primary human non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 1101-8. PMID 22617243 DOI: 10.1097/Jto.0B013E3182519D4D  0.68
2012 Iakovlev V, Siegel ER, Tsao MS, Haun RS. Expression of kallikrein-related peptidase 7 predicts poor prognosis in patients with unresectable pancreatic ductal adenocarcinoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1135-42. PMID 22573795 DOI: 10.1158/1055-9965.Epi-11-1079  0.68
2012 Hai J, Zhu CQ, Bandarchi B, Wang YH, Navab R, Shepherd FA, Jurisica I, Tsao MS. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 1914-24. PMID 22307136 DOI: 10.1158/1078-0432.Ccr-11-2893  0.68
2012 Ibrahimov E, Pham N, Meng F, Sukhram M, Chadwick D, Serra S, Shaw P, Rowsell C, Law C, McPherson J, Gallinger S, Tsao M. Abstract B91: Primary tumor xenograft establishment from pancreatic resection specimens. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-B91  0.32
2012 Leung L, Radulovich N, Park CJ, To C, Ibrahimov E, Bandarchi B, Tsao M. Abstract B102: Expression of KRASG12V and loss of Smad4 contribute to pancreatic duct cell carcinogenesis. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-B102  0.76
2012 Begley KN, Mukhopadhyay D, Petersen GM, Protopopov A, Thayer S, Chin L, Ibrahimov E, Shaw P, Hudson T, Gallinger S, Tsao M, Stein L, McPherson JD, Muthuswamy L, Beck T, et al. Abstract A9: The pancreatic ductal adenocarcinoma project at the Ontario Institute for Cancer Research. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-A9  0.32
2012 Moran MF, To C, Wei Y, Li L, Taylor P, Ignatchenko V, Strumpf D, Tong J, Pham N, Jurisica I, Muthuswamy L, Kislinger T, Tsao M. Abstract 5127: Characterization of lung cancers by integrated genomic and proteomic analysis Cancer Research. 72: 5127-5127. DOI: 10.1158/1538-7445.Am2012-5127  0.32
2012 To C, Strumpf D, Panchal D, Li M, Pham N, Xie W, Yanagawa N, Bandarchi B, Chui MH, Der S, Shepherd FA, Kislinger T, Moran M, Jurisica I, Muthuswamy L, ... Tsao M, et al. Abstract 5069: Genomic profiles of primary non-small cell lung cancer (NSCLC) xenograft tumors identify distinct gene signatures associated with histological subtypes Cancer Research. 72: 5069-5069. DOI: 10.1158/1538-7445.Am2012-5069  0.32
2012 Wei Y, Taylor P, Tong J, Pham N, Li M, Panchal D, To C, Chui MH, Tsao M, Kislinger T, Moran MF. Abstract 4805: Distinctive phospho-proteome signatures in non-small cell lung carcinoma tumors Cancer Research. 72: 4805-4805. DOI: 10.1158/1538-7445.Am2012-4805  0.32
2011 Hammerman PS, Sos ML, Ramos AH, Xu C, Dutt A, Zhou W, Brace LE, Woods BA, Lin W, Zhang J, Deng X, Lim SM, Heynck S, Peifer M, Simard JR, ... ... Tsao MS, et al. Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discovery. 1: 78-89. PMID 22328973 DOI: 10.1158/2159-8274.Cd-11-0005  0.68
2011 Waldron L, Pintilie M, Tsao MS, Shepherd FA, Huttenhower C, Jurisica I. Optimized application of penalized regression methods to diverse genomic data. Bioinformatics (Oxford, England). 27: 3399-406. PMID 22156367 DOI: 10.1093/Bioinformatics/Btr591  0.68
2011 Starczynowski DT, Lockwood WW, Deléhouzée S, Chari R, Wegrzyn J, Fuller M, Tsao MS, Lam S, Gazdar AF, Lam WL, Karsan A. TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer. The Journal of Clinical Investigation. 121: 4095-105. PMID 21911935 DOI: 10.1172/Jci58818  0.68
2011 Noyce RS, Bondre DG, Ha MN, Lin LT, Sisson G, Tsao MS, Richardson CD. Tumor cell marker pvrl4 (nectin 4) is an epithelial cell receptor for measles virus Plos Pathogens. 7. PMID 21901103 DOI: 10.1371/journal.ppat.1002240  0.68
2011 Navab R, Strumpf D, Bandarchi B, Zhu CQ, Pintilie M, Ramnarine VR, Ibrahimov E, Radulovich N, Leung L, Barczyk M, Panchal D, To C, Yun JJ, Der S, Shepherd FA, ... ... Tsao MS, et al. Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America. 108: 7160-5. PMID 21474781 DOI: 10.1073/Pnas.1014506108  0.68
2011 Radulovich N, Leung L, Tsao MS. Modified gateway system for double shRNA expression and Cre/lox based gene expression. Bmc Biotechnology. 11: 24. PMID 21418658 DOI: 10.1186/1472-6750-11-24  0.68
2011 Allen TD, Zhu CQ, Jones KD, Yanagawa N, Tsao MS, Bishop JM. Interaction between MYC and MCL1 in the genesis and outcome of non-small-cell lung cancer. Cancer Research. 71: 2212-21. PMID 21406400 DOI: 10.1158/0008-5472.Can-10-3590  0.68
2011 John T, Kohler D, Pintilie M, Yanagawa N, Pham NA, Li M, Panchal D, Hui F, Meng F, Shepherd FA, Tsao MS. The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 134-41. PMID 21081655 DOI: 10.1158/1078-0432.Ccr-10-2224  0.68
2011 Wei Y, Tong J, Taylor P, Strumpf D, Ignatchenko V, Pham NA, Yanagawa N, Liu G, Jurisica I, Shepherd FA, Tsao MS, Kislinger T, Moran MF. Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures. Journal of Proteome Research. 10: 161-74. PMID 20815376 DOI: 10.1021/Pr100491E  0.68
2011 Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, Mirabello L, Jacobs K, Wheeler W, Yeager M, Bergen AW, Li Q, Consonni D, Pesatori AC, Wacholder S, ... ... Tsao MS, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma (The American Journal of Human Genetics (2009) 85 (679-691)) American Journal of Human Genetics. 88: 861. DOI: 10.1016/j.ajhg.2011.05.003  0.68
2010 Tsao MS. Fibroblast growth factor inhibitors Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 5. PMID 21102237 DOI: 10.1097/01.Jto.0000391364.18141.9D  0.68
2010 Boutros PC, Pintilie M, John T, Starmans MH, Der SD, Shepherd FA, Tsao MS, Jurisica I. Re: Gene expression-based prognostic signatures in lung cancer: ready for clinical use? Journal of the National Cancer Institute. 102: 1677-8; author reply. PMID 20921041 DOI: 10.1093/Jnci/Djq385  0.68
2010 Zhu CQ, Ding K, Strumpf D, Weir BA, Meyerson M, Pennell N, Thomas RK, Naoki K, Ladd-Acosta C, Liu N, Pintilie M, Der S, Seymour L, Jurisica I, Shepherd FA, ... Tsao MS, et al. Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 4417-24. PMID 20823422 DOI: 10.1200/Jco.2009.26.4325  0.68
2010 Zhu CQ, Strumpf D, Li CY, Li Q, Liu N, Der S, Shepherd FA, Tsao MS, Jurisica I. Prognostic gene expression signature for squamous cell carcinoma of lung. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5038-47. PMID 20739434 DOI: 10.1158/1078-0432.CCR-10-0612  0.68
2010 Chari R, Lonergan KM, Pikor LA, Coe BP, Zhu CQ, Chan TH, MacAulay CE, Tsao MS, Lam S, Ng RT, Lam WL. A sequence-based approach to identify reference genes for gene expression analysis. Bmc Medical Genomics. 3: 32. PMID 20682026 DOI: 10.1186/1755-8794-3-32  0.68
2010 Jiang Z, Deng T, Jones R, Li H, Herschkowitz JI, Liu JC, Weigman VJ, Tsao MS, Lane TF, Perou CM, Zacksenhaus E. Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status. The Journal of Clinical Investigation. 120: 3296-309. PMID 20679727 DOI: 10.1172/Jci41490  0.68
2010 Lockwood WW, Chari R, Coe BP, Thu KL, Garnis C, Malloff CA, Campbell J, Williams AC, Hwang D, Zhu CQ, Buys TP, Yee J, English JC, Macaulay C, Tsao MS, et al. Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma. Plos Medicine. 7: e1000315. PMID 20668658 DOI: 10.1371/Journal.Pmed.1000315  0.68
2010 Chung CT, Santos Gda C, Hwang DM, Ludkovski O, Pintilie M, Squire JA, Tsao MS. FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma. Journal of Clinical Pathology. 63: 630-4. PMID 20591913 DOI: 10.1136/Jcp.2010.076794  0.68
2010 Brenner DR, Hung RJ, Tsao MS, Shepherd FA, Johnston MR, Narod S, Rubenstein W, McLaughlin JR. Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors. Bmc Cancer. 10: 285. PMID 20546590 DOI: 10.1186/1471-2407-10-285  0.68
2010 Dokouhaki P, Han M, Joe B, Li M, Johnston MR, Tsao MS, Zhang L. Adoptive immunotherapy of cancer using ex vivo expanded human γδ T cells: A new approach Cancer Letters. 297: 126-136. PMID 20537791 DOI: 10.1016/J.Canlet.2010.05.005  0.68
2010 Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, ... ... Tsao MS, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 463: 899-905. PMID 20164920 DOI: 10.1038/Nature08822  0.68
2010 Lonergan KM, Chari R, Coe BP, Wilson IM, Tsao MS, Ng RT, Macaulay C, Lam S, Lam WL. Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE. Plos One. 5: e9162. PMID 20161782 DOI: 10.1371/Journal.Pone.0009162  0.68
2010 Radulovich N, Pham NA, Strumpf D, Leung L, Xie W, Jurisica I, Tsao MS. Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma. Molecular Cancer. 9: 24. PMID 20113529 DOI: 10.1186/1476-4598-9-24  0.68
2010 Shepherd FA, Tsao MS. Epidermal growth factor receptor biomarkers in non-small-cell lung cancer: A riddle, wrapped in a mystery, inside an enigma Journal of Clinical Oncology. 28: 903-905. PMID 20100955 DOI: 10.1200/Jco.2009.26.3996  0.68
2010 Sridhar SS, Hotte SJ, Chin JL, Hudes GR, Gregg R, Trachtenberg J, Wang L, Tran-Thanh D, Pham NA, Tsao MS, Hedley D, Dancey JE, Moore MJ. A multicenter phase II clinical trial of lapatinib (GW572016) in hormonally untreated advanced prostate cancer. American Journal of Clinical Oncology. 33: 609-13. PMID 20042973 DOI: 10.1097/Coc.0B013E3181Beac33  0.68
2010 Menezes RJ, Roberts HC, Paul NS, McGregor M, Chung TB, Patsios D, Weisbrod G, Herman S, Pereira A, McGregor A, Dong Z, Sitartchouk I, Boerner S, Tsao MS, Keshavjee S, et al. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Lung Cancer (Amsterdam, Netherlands). 67: 177-83. PMID 19427055 DOI: 10.1016/J.Lungcan.2009.03.030  0.68
2010 Hai J, Radulovich N, Zhu C, Der SD, Jurisica I, Tsao M. Abstract 5049: Functional significance ofL1CAMin non-small cell lung cancer Cancer Research. 70: 5049-5049. DOI: 10.1158/1538-7445.Am10-5049  0.76
2010 Leung LH, Radulovich N, Tsao M. Abstract 3133: In vitro modeling of human pancreatic duct epithelial cell transformation Cancer Research. 70: 3133-3133. DOI: 10.1158/1538-7445.Am10-3133  0.76
2010 Radulovich N, Leung L, Navab R, Thu K, Lam W, Tsao M. Abstract 1091: The role for retinoblastoma-like p130 (RBL2) and DNA damage response in human pancreatic cancer cells Cancer Research. 70: 1091-1091. DOI: 10.1158/1538-7445.Am10-1091  0.76
2009 Lara-Guerra H, Waddell TK, Salvarrey MA, Joshua AM, Chung CT, Paul N, Boerner S, Sakurada A, Ludkovski O, Ma C, Squire J, Liu G, Shepherd FA, Tsao MS, Leighl NB. Phase II study of preoperative gefitinib in clinical stage I non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6229-36. PMID 19884551 DOI: 10.1200/Jco.2009.22.3370  0.68
2009 Zhu CQ, Pintilie M, John T, Strumpf D, Shepherd FA, Der SD, Jurisica I, Tsao MS. Understanding prognostic gene expression signatures in lung cancer. Clinical Lung Cancer. 10: 331-40. PMID 19808191 DOI: 10.3816/Clc.2009.N.045  0.68
2009 Geismann C, Morscheck M, Koch D, Bergmann F, Ungefroren H, Arlt A, Tsao MS, Bachem MG, Altevogt P, Sipos B, Fölsch UR, Schäfer H, Müerköster SS. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer. Cancer Research. 69: 4517-26. PMID 19435915 DOI: 10.1158/0008-5472.Can-08-3493  0.68
2009 Boutros PC, Lau SK, Pintilie M, Liu N, Shepherd FA, Der SD, Tsao MS, Penn LZ, Jurisica I. Prognostic gene signatures for non-small-cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America. 106: 2824-8. PMID 19196983 DOI: 10.1073/Pnas.0809444106  0.68
2009 Anraku M, Waddell TK, de Perrot M, Lewis SJ, Pierre AF, Darling GE, Johnston MR, Zener RE, Rampersaud YR, Shepherd FA, Leighl N, Bezjak A, Sun AY, Hwang DM, Tsao MS, et al. Induction chemoradiotherapy facilitates radical resection of T4 non-small cell lung cancer invading the spine. The Journal of Thoracic and Cardiovascular Surgery. 137: 441-447.e1. PMID 19185167 DOI: 10.1016/J.Jtcvs.2008.09.035  0.68
2009 Buys TP, Aviel-Ronen S, Waddell TK, Lam WL, Tsao MS. Defining genomic alteration boundaries for a combined small cell and non-small cell lung carcinoma. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 4: 227-39. PMID 19179901 DOI: 10.1097/Jto.0B013E3181952678  0.68
2009 Sakurada A, Tsao MS. Predictive biomarkers for EGFR therapy Idrugs. 12: 34-38. PMID 19127503  0.68
2009 Lo M, Tsao MS, Hedley D, Ling V. Gene expression profiling of adenosine triphosphate-binding cassette transporters in response to K-ras activation and hypoxia in human pancreatic cancer cell cultures. Pancreas. 38: 85-93. PMID 19117087 DOI: 10.1097/Mpa.0B013E318184Aa8A  0.68
2008 Dahele M, Hwang D, Peressotti C, Sun L, Kusano M, Okhai S, Darling G, Yaffe M, Caldwell C, Mah K, Hornby J, Ehrlich L, Raphael S, Tsao M, Behzadi A, et al. Developing a methodology for three-dimensional correlation of PET-CT images and whole-mount histopathology in non-small-cell lung cancer. Current Oncology (Toronto, Ont.). 15: 62-9. PMID 19008992 DOI: 10.3747/Co.V15I5.349  0.68
2008 Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, Cheung CC, Khan F, Itie-Youten A, Wakeham A, Tsao MS, Iovanna JL, Squire J, Jurisica I, Kaplan D, Melino G, et al. TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes & Development. 22: 2677-91. PMID 18805989 DOI: 10.1101/Gad.1695308  0.68
2008 Müerköster SS, Werbing V, Koch D, Sipos B, Ammerpohl O, Kalthoff H, Tsao MS, Fölsch UR, Schäfer H. Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma--epigenetic downregulation of caspases. International Journal of Cancer. Journal International Du Cancer. 123: 1751-60. PMID 18649362 DOI: 10.1002/Ijc.23703  0.68
2008 Aviel-Ronen S, Coe BP, Lau SK, da Cunha Santos G, Zhu CQ, Strumpf D, Jurisica I, Lam WL, Tsao MS. Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features. Proceedings of the National Academy of Sciences of the United States of America. 105: 10155-60. PMID 18632575 DOI: 10.1073/Pnas.0709618105  0.68
2008 Zhu CQ, da Cunha Santos G, Ding K, Sakurada A, Cutz JC, Liu N, Zhang T, Marrano P, Whitehead M, Squire JA, Kamel-Reid S, Seymour L, Shepherd FA, Tsao MS. Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 4268-75. PMID 18626007 DOI: 10.1200/Jco.2007.14.8924  0.68
2008 Anraku M, Cunningham KS, Yun Z, Tsao MS, Zhang L, Keshavjee S, Johnston MR, de Perrot M. Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma. The Journal of Thoracic and Cardiovascular Surgery. 135: 823-9. PMID 18374762 DOI: 10.1016/J.Jtcvs.2007.10.026  0.68
2008 Radulovich N, Qian JY, Tsao MS. Human pancreatic duct epithelial cell model for KRAS transformation. Methods in Enzymology. 439: 1-13. PMID 18374152 DOI: 10.1016/S0076-6879(07)00401-6  0.68
2008 Seiden-Long I, Navab R, Shih W, Li M, Chow J, Zhu CQ, Radulovich N, Saucier C, Tsao MS. Gab1 but not Grb2 mediates tumor progression in Met overexpressing colorectal cancer cells. Carcinogenesis. 29: 647-55. PMID 18192688 DOI: 10.1093/Carcin/Bgn009  0.68
2008 Salahshor S, Naidoo R, Serra S, Shih W, Tsao MS, Chetty R, Woodgett JR. Frequent accumulation of nuclear E-cadherin and alterations in the Wnt signaling pathway in esophageal squamous cell carcinomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 21: 271-81. PMID 18084253 DOI: 10.1038/Modpathol.3800990  0.68
2007 Lau SK, Boutros PC, Pintilie M, Blackhall FH, Zhu CQ, Strumpf D, Johnston MR, Darling G, Keshavjee S, Waddell TK, Liu N, Lau D, Penn LZ, Shepherd FA, Jurisica I, ... ... Tsao MS, et al. Three-gene prognostic classifier for early-stage non small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 5562-9. PMID 18065728 DOI: 10.1200/Jco.2007.12.0352  0.68
2007 Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R, Lin WM, Province MA, Kraja A, Johnson LA, Shah K, Sato M, Thomas RK, Barletta JA, Borecki IB, ... ... Tsao MS, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature. 450: 893-8. PMID 17982442 DOI: 10.1038/Nature06358  0.68
2007 Agulnik M, Cohen EW, Cohen RB, Chen EX, Vokes EE, Hotte SJ, Winquist E, Laurie S, Hayes DN, Dancey JE, Brown S, Pond GR, Lorimer I, Daneshmand M, Ho J, ... Tsao MS, et al. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 3978-84. PMID 17761983 DOI: 10.1200/Jco.2007.11.8612  0.68
2007 Zhu CQ, Popova SN, Brown ER, Barsyte-Lovejoy D, Navab R, Shih W, Li M, Lu M, Jurisica I, Penn LZ, Gullberg D, Tsao MS. Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 104: 11754-9. PMID 17600088 DOI: 10.1073/Pnas.0703040104  0.68
2007 Tsao MS, Liu G, Shepherd FA. Serum proteomic classifier for predicting response to epidermal growth factor receptor inhibitor therapy: have we built a better mousetrap? Journal of the National Cancer Institute. 99: 826-827. PMID 17551136 DOI: 10.1093/Jnci/Djk221  0.68
2007 Tsao MS. Should mutational analyses of tumor samples bypass histopathology? Journal of Thoracic Oncology. 2: 375-376. PMID 17473650 DOI: 10.1097/01.Jto.0000268668.64625.F2  0.68
2007 Tai MH, Upham BL, Olson LK, Tsao MS, Reed DN, Trosko JE. Cigarette smoke components inhibited intercellular communication and differentiation in human pancreatic ductal epithelial cells. International Journal of Cancer. Journal International Du Cancer. 120: 1855-62. PMID 17266035 DOI: 10.1002/Ijc.22530  0.68
2006 Yun JJ, Heisler LE, Hwang IIL, Wilkins O, Lau SK, Hyrcza M, Jayabalasingham B, Jin J, McLaurin J, Tsao MS, Der SD. Genomic DNA functions as a universal external standard in quantitative real-time PCR Nucleic Acids Research. 34: e85. PMID 16840529 DOI: 10.1093/Nar/Gkl400  0.68
2006 Lonergan KM, Chari R, Deleeuw RJ, Shadeo A, Chi B, Tsao MS, Jones S, Marra M, Ling V, Ng R, Macaulay C, Lam S, Lam WL. Identification of novel lung genes in bronchial epithelium by serial analysis of gene expression. American Journal of Respiratory Cell and Molecular Biology. 35: 651-61. PMID 16809635 DOI: 10.1165/Rcmb.2006-0056Oc  0.68
2006 Costa DB, Dayaram T, D'Alo F, Wouters BJ, Tenen DG, Meyerson M, Tsao MS, Halmos B. C/EBP alpha mutations in lung cancer. Lung Cancer (Amsterdam, Netherlands). 53: 253-4. PMID 16765476 DOI: 10.1016/J.Lungcan.2006.04.011  0.68
2006 Shepherd FA, Tsao MS. Unraveling the mystery of prognostic and predictive factors in epidermal growth factor receptor therapy [1] Journal of Clinical Oncology. 24: 1219-1220. PMID 16505443 DOI: 10.1200/Jco.2005.04.4420  0.68
2006 Allen T, van Tuyl M, Iyengar P, Jothy S, Post M, Tsao MS, Lobe CG. Grg1 acts as a lung-specific oncogene in a transgenic mouse model. Cancer Research. 66: 1294-301. PMID 16452182 DOI: 10.1158/0008-5472.Can-05-1634  0.68
2006 Chetty R, Serra S, Salahshor S, Alsaad K, Shih W, Blaszyk H, Woodgett JR, Tsao MS. Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis. Human Pathology. 37: 212-7. PMID 16426922 DOI: 10.1016/J.Humpath.2005.11.002  0.68
2005 Tsao MS, Sakurada A, Cutz JC, Zhu CQ, Kamel-Reid S, Squire J, Lorimer I, Zhang T, Liu N, Daneshmand M, Marrano P, da Cunha Santos G, Lagarde A, Richardson F, Seymour L, et al. Erlotinib in lung cancer - molecular and clinical predictors of outcome. The New England Journal of Medicine. 353: 133-44. PMID 16014883 DOI: 10.1056/Nejmoa050736  0.68
2005 Lewis AM, Ough M, Hinkhouse MM, Tsao MS, Oberley LW, Cullen JJ. Targeting NAD(P)H:quinone oxidoreductase (NQO1) in pancreatic cancer. Molecular Carcinogenesis. 43: 215-24. PMID 16003741 DOI: 10.1002/mc.20107  0.68
2005 Garnis C, Davies JJ, Buys TP, Tsao MS, MacAulay C, Lam S, Lam WL. Chromosome 5p aberrations are early events in lung cancer: implication of glial cell line-derived neurotrophic factor in disease progression. Oncogene. 24: 4806-12. PMID 15870700 DOI: 10.1038/Sj.Onc.1208643  0.68
2005 Kim RH, Peters M, Jang Y, Shi W, Pintilie M, Fletcher GC, DeLuca C, Liepa J, Zhou L, Snow B, Binari RC, Manoukian AS, Bray MR, Liu FF, Tsao MS, et al. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell. 7: 263-73. PMID 15766664 DOI: 10.1016/J.Ccr.2005.02.010  0.68
2005 Coe BP, Henderson LJ, Garnis C, Tsao MS, Gazdar AF, Minna J, Lam S, Macaulay C, Lam WL. High-resolution chromosome arm 5p array CGH analysis of small cell lung carcinoma cell lines. Genes, Chromosomes & Cancer. 42: 308-13. PMID 15611929 DOI: 10.1002/Gcc.20137  0.68
2004 Blackhall FH, Pintilie M, Wigle DA, Jurisica I, Liu N, Radulovich N, Johnston MR, Keshavjee S, Tsao MS. Stability and heterogeneity of expression profiles in lung cancer specimens harvested following surgical resection. Neoplasia (New York, N.Y.). 6: 761-7. PMID 15720802 DOI: 10.1593/Neo.04301  0.68
2004 Blackhall FH, Wigle DA, Jurisica I, Pintilie M, Liu N, Darling G, Johnston MR, Keshavjee S, Waddell T, Winton T, Shepherd FA, Tsao MS. Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray study. Lung Cancer (Amsterdam, Netherlands). 46: 197-204. PMID 15474668 DOI: 10.1016/J.Lungcan.2004.04.002  0.68
2004 Navab R, Gonzalez-Santos JM, Johnston MR, Liu J, Brodt P, Tsao MS, Hu J. Expression of chicken ovalbumin upstream promoter-transcription factor II enhances invasiveness of human lung carcinoma cells. Cancer Research. 64: 5097-105. PMID 15289311 DOI: 10.1158/0008-5472.Can-03-1185  0.68
2004 Liu J, Blackhall F, Seiden-Long I, Jurisica I, Navab R, Liu N, Radulovich N, Wigle D, Sultan M, Hu J, Tsao MS, Johnston MR. Modeling of lung cancer by an orthotopically growing H460SM variant cell line reveals novel candidate genes for systemic metastasis. Oncogene. 23: 6316-24. PMID 15247903 DOI: 10.1038/Sj.Onc.1207795  0.68
2004 Wigle DA, Tsao M, Jurisica I. Making sense of lung-cancer gene-expression profiles Genome Biology. 5. PMID 14759255 DOI: 10.1186/Gb-2004-5-2-309  0.68
2003 Tai MH, Olson LK, Madhukar BV, Linning KD, Van Camp L, Tsao MS, Trosko JE. Characterization of gap junctional intercellular communication in immortalized human pancreatic ductal epithelial cells with stem cell characteristics. Pancreas. 26: e18-26. PMID 12499933 DOI: 10.1097/00006676-200301000-00025  0.68
2002 Iyengar P, Tsao MS. Clinical relevance of molecular markers in lung cancer Surgical Oncology. 11: 167-179. PMID 12450553 DOI: 10.1016/S0960-7404(02)00047-6  0.68
2002 Wang KK, Liu N, Radulovich N, Wigle DA, Johnston MR, Shepherd FA, Minden MD, Tsao MS. Novel candidate tumor marker genes for lung adenocarcinoma. Oncogene. 21: 7598-604. PMID 12386823 DOI: 10.1038/sj.onc.1205953  0.68
2002 Sultan M, Wigle DA, Cumbaa CA, Maziarz M, Glasgow J, Tsao MS, Jurisica I. Binary tree-structured vector quantization approach to clustering and visualizing microarray data. Bioinformatics (Oxford, England). 18: S111-9. PMID 12169538 DOI: 10.1093/bioinformatics/18.suppl_1.S111  0.68
2002 To C, Seiden I, Liu N, Wigle D, Tsao MS. High expression of Met/hepatocyte growth factor receptor suppresses tumorigenicity in NCI-H1264 lung carcinoma cells. Experimental Cell Research. 273: 45-53. PMID 11795945 DOI: 10.1006/excr.2001.5433  0.32
2001 Parsons MJ, Jones RG, Tsao MS, Odermatt B, Ohashi PS, Woodgett JR. Expression of active protein kinase B in T cells perturbs both T and B cell homeostasis and promotes inflammation. Journal of Immunology (Baltimore, Md. : 1950). 167: 42-8. PMID 11418630 DOI: 10.4049/Jimmunol.167.1.42  0.68
2001 Tsao MS. Primary pulmonary primitive neuroectodermal tumor (PNET) Pathology Research and Practice. 197: 121-122.  0.68
2000 Yi S, Tsao MS. Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line Neoplasia. 2: 226-234. PMID 10935508 DOI: 10.1038/Sj.Neo.7900080  0.68
2000 Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature. 406: 86-90. PMID 10894547 DOI: 10.1038/35017574  0.68
2000 Tammemagi MC, Mclaughlin JR, Mullen JBM, Bull SB, Johnston MR, Tsao MS, Casson AG. A study of smoking, p53 tumor suppressor gene alterations and non-small cell lung cancer Annals of Epidemiology. 10: 176-185. PMID 10813511 DOI: 10.1016/S1047-2797(99)00048-4  0.68
1998 Tsao M, Liu N, Chen J, Pappas J, Ho J, To C, Viallet J, Park M, Zhu H. Differential expression of Met/hepatocyte growth factor receptor in subtypes of non-small cell lung cancers Lung Cancer. 20: 1-16. PMID 9699182 DOI: 10.1016/S0169-5002(98)00007-5  0.32
1998 To CTT, Tsao MS. The roles of hepatocyte growth factor/scatter factor and Met receptor in human cancers (Review) Oncology Reports. 5: 1013-1024. PMID 9683803  0.68
1998 Tsao MS. Histopathology and molecular pathology of pancreatic neoplasms Current Oncology. 5.  0.68
1998 To C, Tsao MS. Effect of RAS oncogene activation on Met/hepatocyte growth factor receptor over-expression in non-small cell lung cancer cells Faseb Journal. 12.  0.68
1997 Casson AG, Wilson SM, Mccart JA, O'Malley FP, Ozcelik H, Tsao MS, Chambers AF. ras mutation and expression of the ras-regulated genes osteopontin and cathepsin L in human esophageal cancer International Journal of Cancer. 72: 739-745. PMID 9311587 DOI: 10.1002/(Sici)1097-0215(19970904)72:5<739::Aid-Ijc6>3.0.Co;2-T  0.68
1997 Couchman GM, Bentley R, Tsao MS, Raszmann K, McLachlan JA, Walmer DK. p53(lyn) and p56(lyn): A new signaling pathway in human endometrium and endometrial adenocarcinomas Journal of the Society For Gynecologic Investigation. 4: 103-109. PMID 9101470 DOI: 10.1016/S1071-5576(97)00011-7  0.68
1996 Marcus VA, Viloria J, Owen D, Tsao MS. Malignant rhabdoid tumor of the colon: Report of a case with molecular analysis Diseases of the Colon and Rectum. 39: 1322-1326. PMID 8918447 DOI: 10.1007/Bf02055131  0.68
1996 Viallet J, Tsao MS, Gallant G. Etoposide and doxorubicin antagonize the in vitro activity of paclitaxel in human non-small cell lung cancer cell lines Lung Cancer. 15: 93-101. PMID 8865127 DOI: 10.1016/0169-5002(96)00574-0  0.68
1996 Tsao MS, Zhu H, Viallet J. Autocrine growth loop of the epidermal growth factor receptor in normal and immortalized human bronchial epithelial cells Experimental Cell Research. 223: 268-273. PMID 8601403 DOI: 10.1006/Excr.1996.0081  0.68
1994 Frankel A, Tsao MS, Viallet J. Receptor Subtype Expression and Responsiveness to Bombesin in Cultured Human Bronchial Epithelial Cells Cancer Research. 54: 1613-1616. PMID 8137267  0.68
1994 Zhang X, Wang T, Tsao MS, Batist G. Transforming Growth Factor β1 Promotes Spontaneous Transformation of Cultured Rat Liver Epithelial Cells Cancer Research. 54: 6122-6128. PMID 7954458  0.68
1993 Liu C, Tsao MS. Proto-oncogene and growth factor/receptor expression in the establishment of primary human non-small cell lung carcinoma cell lines American Journal of Pathology. 142: 413-423. PMID 8382008  0.68
1993 Liu C, Tsao MS. In vitro and in vivo expressions of transforming growth factor-α and tyrosine kinase receptors in human non-small-cell lung carcinomas American Journal of Pathology. 142: 1155-1162. PMID 8097369  0.68
1993 Tsao MS. Enhanced expression of alpha-fetoprotein gene in cultured rat liver epithelial cells treated with N-methyl-N’-nitro-N-nitrosoguanidine Pathobiology. 61: 25-30. PMID 7692873 DOI: 10.1159/000163756  0.68
1992 Liu C, Park M, Tsao MS. Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas Oncogene. 7: 181-185. PMID 1741162  0.68
1992 Tsao MS, Zhang XY. The effects of continuous exposure to epidermal growth factor on the spontaneous transformation of cultured rat liver epithelial cells American Journal of Pathology. 140: 85-94. PMID 1731531  0.68
1991 Phillips NC, Tsao MS. Liposomal muramyl dipeptide therapy of experimental M5076 liver metastases in mice Cancer Immunology Immunotherapy. 33: 85-90. PMID 2036662 DOI: 10.1007/Bf01742534  0.68
1991 Batist G, Woo A, Tsao MS. Effect of proliferative state on glutathione s-transferase isoenzyme in cultured rat liver epithelial cells Carcinogenesis. 12: 2031-2034. PMID 1934287 DOI: 10.1093/Carcin/12.11.2031  0.68
1991 Tsao MS, Fraser RS. Primary pulmonary adenocarcinoma with enteric differentiation. Cancer. 68: 1754-7. PMID 1913519 DOI: 10.1002/1097-0142(19911015)68:8<1754::Aid-Cncr2820680818>3.0.Co;2-E  0.68
1991 Tsao MS, Grisham JW. Expression of protein disulfide isomerase in cultured rat liver epithelial cells is unrelated to the growth inhibitory effect of TGF-β1 Biochemical and Biophysical Research Communications. 174: 478-482. PMID 1704224 DOI: 10.1016/0006-291X(91)91441-E  0.68
1990 Shepherd J, Tsao MS, Duguid WP. Genotoxicity of pancreatic chemical carcinogens to propagable cultured normal pancreatic epithelial cells Experimental and Molecular Pathology. 53: 203-210. PMID 2147910 DOI: 10.1016/0014-4800(90)90044-E  0.68
1990 Liu C, Woo A, Tsao MS. Expression of transforming growth factor-alpha in primary human colon and lung carcinomas British Journal of Cancer. 62: 425-429. PMID 1698444 DOI: 10.1038/bjc.1990.311  0.68
1990 Tsao MS, Shepherd J, Batist G. Phenotypic Expression in Spontaneously Transformed Cultured Rat Liver Epithelial Cells Cancer Research. 50: 1941-1947. PMID 1689614  0.68
1989 Tsao MS. Hepatic sinusoidal fibrosis in agnogenic myeloid metaplasia American Journal of Clinical Pathology. 91: 302-305. PMID 2923095 DOI: 10.1093/Ajcp/91.3.302  0.68
1989 Phillips NC, Tsao MS. Inhibition of Experimental Liver Tumor Growth in Mice by Liposomes Containing a Lipophilic Muramyl Dipeptide Derivative Cancer Research. 49: 936-939. PMID 2912563  0.68
1989 Tsao MS, Duong M, Batist G. Glutathione and glutathione S-transferases in clones of cultured rat liver epithelial cells that express varying activity of γ-glutamyl transpeptidase Molecular Carcinogenesis. 2: 144-149. PMID 2477028 DOI: 10.1002/Mc.2940020307  0.68
1988 Liu C, Tsao MS, Grisham JW. Transforming Growth Factors Produced by Normal and Neoplastically Transformed Rat Liver Epithelial Cells in Culture Cancer Research. 48: 850-855. PMID 3276400  0.68
1988 Tsao MS, Liu C. Inhibition of growth of early passage normal rat liver epithelial cell lines by epidermal growth factor Laboratory Investigation. 58: 637-642. PMID 3259995  0.68
1988 Tsao MS, Batist G. Induction of gamma-glutamyl transpeptidase activity by all-trans retinoic acid in cultured rat liver epithelial cells Biochemical and Biophysical Research Communications. 157: 1039-1045. PMID 2905127 DOI: 10.1016/S0006-291X(88)80979-3  0.68
1987 Tsao MS, Duguid WP. Establishment of propagable epithelial cell lines from normal adult rat pancreas Experimental Cell Research. 168: 365-375. PMID 3803447 DOI: 10.1016/0014-4827(87)90009-7  0.68
1987 Tsao MS, Grisham JW. Phenotypic modulation during tumorigenesis by clones of transformed rat liver epithelial cells Cancer Research. 47: 1282-1286. PMID 2880659  0.68
1985 Tsao MS, Grisham JW, Chou BB, Smith JD. Clonal Isolation of Populations of γ-Glutamyl Transpeptidase-positive and -negative Cells from Rat Liver Epithelial Cells Chemically Transformed in Vitro Cancer Research. 45: 5134-5138. PMID 2862991  0.68
1984 Tsao MS, Smith JD, Nelson KG, Grisham JW. A diploid epithelial cell line from normal adult rat liver with phenotypic properties of 'oval' cells Experimental Cell Research. 154: 38-52. PMID 6468534 DOI: 10.1016/0014-4827(84)90666-9  0.68
1984 Tsao MS, Nelson KG, Grisham JW. Biochemical effects of 12-O-tetradecanoylphorbol-13-acetate, retinoic acid, phenobarbital, and 5-azacytidine on a normal rat liver epithelial cell line Journal of Cellular Physiology. 121: 1-6. PMID 6207184 DOI: 10.1002/Jcp.1041210102  0.68
1983 Tsao MS, Becker L, Finlayson M. Giant cell astrocytoma with histiocytic infiltrate - Definition of a subgroup of monstrocellular brain tumors Acta Neuropathologica. 59: 75-77. PMID 6837271 DOI: 10.1007/BF00690320  0.68
1982 Tsao MS, Schraufnagel D, Wang NS. Pathogenesis of pulmonary infarction The American Journal of Medicine. 72: 599-606. PMID 6462058 DOI: 10.1016/0002-9343(82)90458-2  0.68
1981 Tsao MS, Schraufnagel D, Wang NS. Pulmonary metastasis of choriocarcinoma with a miliary roentgenographic pattern Archives of Pathology and Laboratory Medicine. 105: 557-558. PMID 6895173  0.68
1980 Steele A, Tsao MS, Finlayson M. Endocardial fibroelastosis after replacement of mitral valves with tilting disk prostheses. A report of two cases Archives of Pathology and Laboratory Medicine. 104: 422-424. PMID 6893136  0.68
Show low-probability matches.